Billy Dunn’s Prothena Board Position Reignites Ethical Debate
Ex-FDA Neuroscience Director Billy Dunn was appointed to Prothena’s board of directors last week. Industry representatives and regulatory experts weigh in on the potential ethical implications.
Billy Dunn’s Prothena Board Position Reignites Ethical Debate Read More »
